{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"52"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"52"}],"units":"Participants"}],"description":"The toxicity of this combined regimen will be measured using the NCI CTC version 2.0.","groups":[{"description":"Cytarabine, Leucovorin, Methotrexate, Procarbazine, Rituximab, Vincristine: Immunochemotherapy","id":"OG000","title":"Immunocompetent Pts With Newly Diagnosed Primary CNS Lymphoma"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"2 years","title":"Total Number of Participants Who Experienced Acute Treatment Related Adverse Events","type":"PRIMARY","unitOfMeasure":"Participants"}